Latest updates you need to know, quick, clear, and to the point.
Elevidys-treated boys aged 4-7 years with Duchenne showed an increase on the North Star Ambulatory Assessment (NSAA), a...
The World Health Organization (WHO) has published its first-ever Global research agenda on health, migration and displacement to...
RVO is the third indication for Vabysmo, in addition to neovascular or ‘wet’ age-related macular degeneration and diabetic...
Vabysmo achieved its primary endpoint of non-inferiority to aflibercept in RVO in the BALATON and COMINO clinical trialsVabysmo...
77% of early-stage relapsing-remitting multiple sclerosis (RRMS) patients who had not received prior treatment achieved no evidence of...
Gravely concerned by the humanitarian and health situation facing approximately 200 people, including health workers and up to...
Dr Michel Thieren, WHO Special Representative in Israel, spent almost 2 weeks travelling across the country to see...
These Phase III data are the first and only to show an improvement in disease-free survival in early-stage...
Neonatal sepsis is a leading cause of death for newbornsTesting IL-6 can indicate a neonatal sepsis infection earlier...
6 months of conflict in Sudan leave millions of children at risk of cholera, dengue, measles, malaria and...
“Zoonotic disease is one of the areas of concern which is affecting the humans as well as the...
Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on OCREVUS levels in the...